Related Experiment Video

Updated: Jul 19, 2026

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

A conserved RAS/mitogen-activated protein kinase pathway regulates DNA damage-induced cell death postirradiation in

Joanne B Weidhaas1, David M Eisenmann, Justin M Holub

  • 1Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut 06520-8040, USA. joanne.weidhaas@yale.edu

Cancer Research
|November 3, 2006
PubMed

Insights

The epidermal growth factor receptor (EGFR) pathway protects cancer cells from radiation by enhancing DNA repair. This discovery explains why some cancer treatments fail in EGFR-driven tumors.

Area of Science:

  • Cancer Research
  • Molecular Biology
  • Radiation Oncology

Background:

  • The epidermal growth factor receptor (EGFR) signaling pathway is frequently overactive in human cancers, contributing to resistance against cytotoxic therapies.
  • The precise molecular mechanisms underlying EGFR-mediated resistance, particularly concerning cell death pathways, remain poorly understood due to limitations in existing tissue models.
  • Understanding these mechanisms is crucial for developing more effective cancer treatment strategies.

Purpose of the Study:

  • To genetically define the role of the EGFR signaling pathway in protecting against radiation-induced reproductive cell death.
  • To investigate the downstream signaling components of EGFR involved in radioresistance.
  • To elucidate the interaction between the EGFR pathway and the DNA damage response (DDR) in the context of cytotoxic therapy.

Main Methods:

  • Development of a novel model in *Caenorhabditis elegans* called "Radelegans" to study radiation-induced reproductive cell death in isolation.
  • Utilizing the Radelegans model for genetic screens to identify key pathways involved in radioresistance.
  • Employing genetic analysis to determine the position of the EGFR/RAS/MAPK pathway relative to the DNA damage checkpoint and DDR pathways.

Main Results:

  • The RAS/mitogen-activated protein kinase (MAPK) pathway, a downstream component of EGFR signaling, was found to be critical for protection against reproductive cell death in the Radelegans model.
  • RAS/MAPK pathway signaling was shown to act downstream of the DNA damage checkpoint and be genetically linear with the DNA damage response pathway.
  • These findings implicate the RAS/MAPK pathway in mediating DNA repair following cytotoxic therapy, suggesting enhanced repair as a mechanism of resistance.

Conclusions:

  • Enhanced DNA repair, mediated by the EGFR/RAS/MAPK pathway's interaction with the DNA damage response, is a key mechanism of resistance to cytotoxic therapy.
  • The ineffectiveness of current treatment strategies in EGFR/RAS/MAPK pathway-mediated tumors may be explained by this enhanced repair capacity.
  • The Radelegans platform provides a valuable tool for further dissecting the genetic basis of radiation response in tissues and for developing targeted therapies.

More Related Videos

Immunofluorescence Imaging of DNA Damage and Repair Foci in Human Colon Cancer Cells05:18

Immunofluorescence Imaging of DNA Damage and Repair Foci in Human Colon Cancer Cells

Published on: June 9, 2020

Spatial and Temporal Analysis of Active ERK in the C. elegans Germline08:40

Spatial and Temporal Analysis of Active ERK in the C. elegans Germline

Published on: November 29, 2016

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.